ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 3742

$807K Total Retail Price of All Prescriptions

Rank: 263 out of 3742

810 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 810 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 810 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
LOSARTAN-HYDROCHLOROTHIAZIDE 950 780 256 1 42
AMLODIPINE BESYLATE 874 743 219 2 3
OMEPRAZOLE 861 737 225 3 5
METFORMIN HCL 589 508 131 4 6
TRAMADOL HCL 579 472 174 5 17
SIMVASTATIN 513 445 113 6 1
FUROSEMIDE 511 449 104 7 10
ATORVASTATIN CALCIUM 394 347 113 8 7
LOSARTAN POTASSIUM 364 305 103 9 13
CLONIDINE HCL 357 310 96 10 50
METOPROLOL TARTRATE 315 278 73 11 9
DONEPEZIL HCL 297 282 53 12 37
NIFEDIPINE ER 266 217 73 13 76
WARFARIN SODIUM 265 225 39 14 21
NAMENDA 264 259* 21 15 45
LISINOPRIL 262 221 58 16 2
HYDROCODONE-ACETAMINOPHEN 253 214 112 S3 17 8
LEVOTHYROXINE SODIUM 250 218 43 18 4
LANTUS 234 190 52 19 66
ALENDRONATE SODIUM 227 194 52 20 27
CLOPIDOGREL 196 174 42 21 18
MELOXICAM 196 166 52 21 32
GABAPENTIN 190 138 52 23 15
CARVEDILOL 188 145 44 24 23
MUPIROCIN* 186 145 42 25 128
NAPROXEN 180 140 56 26 73
CRESTOR 179 144 39 27 24
NOVOLOG 171 166* 29 28 135
GLIPIZIDE 168 154 45 29 39
LANTUS SOLOSTAR 167 138 34 30 104
ADVAIR DISKUS 166 161* 41 31 55
ALBUTEROL SULFATE 161 112 30 32 172
TAMSULOSIN HCL 156 151* 40 33 33
CITALOPRAM HBR 148 129 34 34 26
POLYETHYLENE GLYCOL 3350 137 125 37 35 139
MIRTAZAPINE 134 129* 37 36 60
QUETIAPINE FUMARATE 127 112 19 A 37 67
CLONAZEPAM 120 115* 42 B 38 44
METOPROLOL SUCCINATE 118 105 25 39 20
NOVOLOG FLEXPEN 117 100 21 40 203
SERTRALINE HCL 115 103 26 41 28
LEVETIRACETAM 114 81 19 42 123
NOVOLIN R 112 81 16 43 160
AZITHROMYCIN 111 98 91 44 40
IPRATROPIUM BROMIDE 108 78 16 45 232
PANTOPRAZOLE SODIUM 103 98* 22 46 34
ATENOLOL 101 96* 22 47 16
TEMAZEPAM 99 76 37 B 48 31
POTASSIUM CHLORIDE 96 72 28 49 22
OXYBUTYNIN CHLORIDE 90 78 27 50 98
ENOXAPARIN SODIUM 89 78 26 51 302
VOLTAREN 89 84* 26 51 61
MEGESTROL ACETATE 86 86 29 R 53 162
FAMOTIDINE* 85 73 20 54 70
LEVEMIR 85 57 14 54 149
HYDRALAZINE HCL 85 62 26 54 95
SURE COMFORT* 84 71 18 57 190
HYDROCHLOROTHIAZIDE 82 70 14 58 11
KLOR-CON M20 79 74* 16 59 129
SURE COMFORT* 75 50 20 60 190
XARELTO 70 <11 <11 61 227
DILTIAZEM HCL 67 62* 14 62 241
RENVELA 67 <11 <11 62 391
IPRATROPIUM-ALBUTEROL 64 59* 29 64 138
GLIMEPIRIDE 63 58* 13 65 41
JANUVIA 63 <11 <11 65 78
ISOSORBIDE MONONITRATE ER 62 50 13 67 68
DIGOX 61 56* 11 68 107
METOCLOPRAMIDE HCL 59 54* 14 69 150
SANTYL 57 52* 17 70 218
ESCITALOPRAM OXALATE 55 50* 11 71 54
ZETIA 55 <11 <11 71 90
RANITIDINE HCL 54 49* 13 73 35
CLOTRIMAZOLE-BETAMETHASONE 54 49* 28 73 94
LATANOPROST 52 47* 11 75 179
LEVOFLOXACIN 50 45* 33 76 89
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.